To Block or Not: Updates in Neuromuscular Blockade in Acute Respiratory Distress Syndrome.

Conclusions: The mortality benefit of NMBAs in ARDS has contradicting evidence with potentially serious adverse effects and notable controversies.
PMID: 32111121 [PubMed - as supplied by publisher]

Source: The Annals of Pharmacotherapy - February 27, 2020 Category: Drugs & Pharmacology Authors: Mefford B, Donaldson JC, Bissell BD Tags: Ann Pharmacother Source Type: research